Mahaley M S, Brooks W H, Roszman T L, Bigner D D, Dudka L, Richardson S
J Neurosurg. 1977 Apr;46(4):467-76. doi: 10.3171/jns.1977.46.4.0467.
Cellular and humoral immune parameters were evaluated in a series of brain-tumor patients, 42 with glioblastoma multiforme, 17 with other anaplastic gliomas, and 17 with meningiomas. A degree of anergy was found, which seems in the group as a whole to be proportional to the degree of anaplasia. In addition, serial bimonthyl testing in individual cases revealed further reduction in certain immune responses coincident with clinical decline.
对一系列脑肿瘤患者的细胞免疫和体液免疫参数进行了评估,其中42例为多形性胶质母细胞瘤,17例为其他间变性胶质瘤,17例为脑膜瘤。发现了一定程度的无反应性,在整个组中,这种无反应性似乎与间变程度成正比。此外,对个别病例每两个月进行一次的连续检测显示,某些免疫反应进一步降低,同时伴有临床症状恶化。